Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Takao

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Biological & Pharmaceutical Bulletin|February 16, 1999
Biological activities of 1,1,6-trisubstituted indanes: beyond magainin 2N Numao, Y Hirota, A Iwahori, et al.
Gene Therapy|December 16, 2014
Inhibition of choroidal fibrovascular membrane formation by new class of RNA interference therapeutic agent targeting periostinT Nakama, S Yoshida, K Ishikawa, et al.
Gene Therapy|August 19, 2017
Oligonucleotide-targeting periostin ameliorates pulmonary fibrosisA Tomaru, T Kobayashi, J A Hinneh, et al.
Procedia in Vaccinology|April 15, 2020
A Novel Therapeutic and Prophylactic Vaccine (HVJ-Envelope / Hsp65 DNA + IL-12 DNA) against Tuberculosis Using the Cynomolgus Monkey ModelM Okada, Y Kita, T Nakajima, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Biological & Pharmaceutical Bulletin|February 16, 1999
Biological activities of 1,1,6-trisubstituted indanes: beyond magainin 2N Numao, Y Hirota, A Iwahori, et al.
Gene Therapy|December 16, 2014
Inhibition of choroidal fibrovascular membrane formation by new class of RNA interference therapeutic agent targeting periostinT Nakama, S Yoshida, K Ishikawa, et al.
Gene Therapy|August 19, 2017
Oligonucleotide-targeting periostin ameliorates pulmonary fibrosisA Tomaru, T Kobayashi, J A Hinneh, et al.
Procedia in Vaccinology|April 15, 2020
A Novel Therapeutic and Prophylactic Vaccine (HVJ-Envelope / Hsp65 DNA + IL-12 DNA) against Tuberculosis Using the Cynomolgus Monkey ModelM Okada, Y Kita, T Nakajima, et al.
Pageof 6